2cureX AB (publ) (2CUREX.ST)
- Previous Close
0.4760 - Open
0.4740 - Bid 0.4380 x --
- Ask 0.4700 x --
- Day's Range
0.4420 - 0.4740 - 52 Week Range
0.2030 - 3.9900 - Volume
11,842 - Avg. Volume
68,458 - Market Cap (intraday)
7.78M - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
-- - EPS (TTM)
-1.5000 - Earnings Date Aug 22, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
2cureX AB (publ) operates as a medtech company in Europe. The company's principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.
www.2curex.comRecent News: 2CUREX.ST
View MorePerformance Overview: 2CUREX.ST
Trailing total returns as of 8/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2CUREX.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2CUREX.ST
View MoreValuation Measures
Market Cap
8.38M
Enterprise Value
5.25M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
111.72
Price/Book (mrq)
3.01
Enterprise Value/Revenue
70.00
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-97.99%
Return on Equity (ttm)
-174.78%
Revenue (ttm)
1.98M
Net Income Avi to Common (ttm)
-26.35M
Diluted EPS (ttm)
-1.5000
Balance Sheet and Cash Flow
Total Cash (mrq)
3.13M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-17.97M